Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone Dynamic Testing for Diagnosis of Central Adrenal Insufficiency
NCT04588688Phase 2Terminated
- Start
- May 2021
- Primary completion
- Aug 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of mifepristone in central adrenal insufficiency (CAI). Started May 2021; status: terminated.
02
Drugs
mifepristone
03
Conditions
central adrenal insufficiency (CAI)
Beyond the preview
Go deeper on NCT04588688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04588688.